Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2012
06/27/2012CN101133829B Wilding mineral composition synthesized five-fruit granules and orange juice beverage and method for processing the same
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207177 Inhibitors of E1 activating enzymes
06/26/2012US8207176 Compounds
06/26/2012US8207168 Pyridazinone derivatives
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2566609C Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/26/2012CA2536185C Drug delivery system by administrating fine particles to sub-tenon
06/26/2012CA2508129C Novel x-conotoxin peptides (-i)
06/26/2012CA2504941C 3-substituted-6-aryl pyridines
06/26/2012CA2503211C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
06/26/2012CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases
06/26/2012CA2371689C Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatment
06/21/2012WO2012082947A1 Compounds and compositions as tgr5 agonists
06/21/2012WO2012082921A1 Cellular activation insulin therapy
06/21/2012WO2012082718A2 3-methanesulfonylpropionitrile for treating inflammation and pain
06/21/2012WO2012081776A1 Composition comprising an extract of phellodendri cortex for the prevention or treatment of pancreatitis.
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081604A1 Composition containing orotic acid, and process for production thereof
06/21/2012WO2012080990A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
06/21/2012WO2012080457A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012WO2012080329A1 Formulations of n-(3,5-dichloropyridin-4-yl)-[1-(4-fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide
06/21/2012WO2012079497A1 Bromfenac organic salts and preparation method, composition and use thereof
06/21/2012WO2012044090A3 Novel aminoquinazoline compound having a protein-kinase inhibiting action
06/21/2012US20120157546 Compositions Containing Aromatic Aldehydes and Their Use in Treatments
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157536 Composition for transdermal administration of non-steroidal anti-flammatory drug
06/21/2012US20120157534 Compositions and methods of treatment for inflammatory diseases
06/21/2012US20120157526 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
06/21/2012US20120157524 3-methanesulfonylpropionitrile for treating inflammation and pain
06/21/2012US20120157523 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
06/21/2012US20120157507 USP47 Inhibtors and Methods to Induce Apoptosis
06/21/2012US20120157506 Novel Imidazole-2-Benzamide Compounds Useful for the Treatment of Osteoarthritis
06/21/2012US20120157497 Compounds having analgesic and/or immunostimulant activity
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120157489 Treatment of endometriosis
06/21/2012US20120157487 Sulfur derivatives as chemokine receptor modulators
06/21/2012US20120157466 Heterocyclic compounds with cxcr3 antagonist activity
06/21/2012US20120157454 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
06/21/2012US20120157453 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157443 Bruton's tyrosine kinase inhibitors
06/21/2012US20120157442 Heteroaryl btk inhibitors
06/21/2012US20120157438 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157436 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
06/21/2012US20120157433 Heteroaryl Compounds as Kinase Inhibitors
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157428 Bromodomain inhibitors and uses thereof
06/21/2012US20120157420 Treatment and prevention of secondary injury after trauma or damage to the central nervous system
06/21/2012US20120157416 xylitol containing comestible product
06/21/2012US20120157415 New Crystalline Form of Pemirolast
06/21/2012US20120157414 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/21/2012US20120157413 Phosphorous derivatives as chemokine receptor modulators
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157410 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157395 Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157381 Compositions and methods for cardiac tissue repair
06/21/2012US20120157380 Pegylated human apoa-1 and process for production thereof
06/21/2012US20120157373 Antimicrobial compounds having protective or therapeutic leaving groups
06/21/2012US20120157372 Human milk peptides
06/21/2012US20120156732 Useful polypeptides
06/21/2012US20120156306 Viral inactivated platelet extract, use and preparation thereof
06/21/2012US20120156296 Antioxidants in fish oil powder and tablets
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156265 Conformable tissue repair implant capable of injection delivery
06/21/2012US20120156248 Augmentation of titer for vaccination in animals
06/21/2012US20120156247 Biocomposition stimulant of the immune system, anti-tumour and anti-hiv
06/21/2012US20120156228 Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156210 Methods of treatment using anti-il-22ra antibodies
06/21/2012US20120156209 Anti-il-tif antibodies and methods of use
06/21/2012US20120156207 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156203 Novel anti-il13 antibodies and uses thereof
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156146 Compositions and Methods for Improving the Appearance of Facial Texture
06/21/2012US20120156144 Foamable Compositions, Kits and Methods for Hyperhidrosis
06/21/2012DE102010063612A1 Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure New multi-component crystals of ([2-amino-6- (4-fluoro-benzylamino) -pyridin-3-yl] -carbamic acid ethyl ester and 2- [2 - [(2,6-dichlorophenyl) -amino] -phenyl] -acetic acid
06/21/2012DE102010063609A1 Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure New multi-component crystals of ([2-amino-6- (4-fluoro-benzylamino) -pyridin-3-yl) -carbamic acid ethyl ester and a arylpropionic
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2820625A1 3-methanesulfonylpropionitrile for treating inflammation and pain
06/21/2012CA2812223A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1272